David Liguang Chenn, founder and Managing Partner of Oceanpine Capital. See contact routes.
David Liguang Chenn, founder and Managing Partner of Oceanpine Capital, invests primarily in growth-stage to late-stage ventures across technology (AI, semiconductors, 5G, cloud), healthcare, biotech, and advanced manufacturing. His portfolio includes notable companies such as Horizon Robotics, Tiger Brokers, Enflame, Ansun BioPharma, and Apexigen, with the firm having invested over $2 billion in more than 100 companies. Chenn’s distinctive thesis emphasizes integrating deep industrial resources to help “hardcore” technology find application scenarios and building defensible competitive barriers, while increasingly shifting toward control-oriented buyouts to reduce IPO reliance.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Central.
Investors like David Liguang Chenn · Full investor directory · Investor access · Company funding database